MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00535-025-02303-2

Медицинская библиотека · Journal of gastroenterology · 2025

Molecular insights into HER2/ERBB2 amplification and carcinogenesis in gallbladder cancer associated with pancreaticobiliary maljunction.

Zhu Ming, Douchi Daisuke, Murakami Keigo, Itoh Taito, Migita Shusuke, Rikiyama Naoki, Hayashi Shuichiro, Kokumai Takashi, Sato Hideaki, Yoshimachi Shingo, Kusaka Akiko, Shimura Mitsuhiro, Nakayama Shun, Aoki Shuichi, Iseki Masahiro, Miura Takayuki, Maeda Shimpei, Ishida Masaharu, Ohtsuka Hideo, Mizuma Masamichi, Nakagawa Kei, Masamune Atsushi, Furukawa Toru, Unno Michiaki

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Pancreaticobiliary maljunction (PBM) contributes to epithelial hyperplasia and, ultimately, the development of gallbladder cancer (GBC). Despite its clinical significance, the molecular and cellular mechanisms driving carcinogenesis in GBC with PBM remain poorly elucidated. This study investigated the oncogenic mechanisms, biomarkers, and performance associated with Erb-b2 receptor tyrosine kinase 2 (ERBB2)-targeted therapies in GBC with PBM.

METHODS

Overall, 127 surgically treated patients were stratified as follows: Group A, normal gallbladder; Group B, PBM; Group C, GBC without PBM; and Group D, GBC with PBM. We performed whole-exome sequencing (WES) for Group D and human epidermal growth factor receptor 2 immunohistochemistry (HercepTest) for the entire cohort. Fluorescence in situ hybridization (FISH) was used to clarify human epidermal growth factor receptor 2 (HER2) expression in cases with equivocal HercepTest results.

RESULTS

ERBB2 amplification was detected in 50% of Group D patients. The proportion of HER2 protein expression scores ≥ 2 + was highest in Group D compared with that in the other groups (50.0% vs. 0% in Groups A and B and 15.6% in Group C) (P = 0.006, chi-squared test). Finally, 37.5% and 13.3% of cases in Groups D and C, respectively, showed HER2 overexpression (P = 0.037, chi-squared test).

CONCLUSIONS

This is the first evaluation of HER2/ERBB2 expression in GBC with PBM based on WES, HercepTest, and FISH. The significant increase in ERBB2 expression, driven by the synergistic interplay between GBC and PBM, underscores a critical molecular interaction that may inform the development of targeted therapeutic strategies.

Для цитирования: Zhu Ming, Douchi Daisuke, Murakami Keigo, Itoh Taito, Migita Shusuke, Rikiyama Naoki, Hayashi Shuichiro, Kokumai Takashi, Sato Hideaki, Yoshimachi Shingo, Kusaka Akiko, Shimura Mitsuhiro, Nakayama Shun, Aoki Shuichi, Iseki Masahiro, Miura Takayuki, Maeda Shimpei, Ishida Masaharu, Ohtsuka Hideo, Mizuma Masamichi, Nakagawa Kei, Masamune Atsushi, Furukawa Toru, Unno Michiaki. Molecular insights into HER2/ERBB2 amplification and carcinogenesis in gallbladder cancer associated with pancreaticobiliary maljunction.. Journal of gastroenterology. 2025. DOI: 10.1007/s00535-025-02303-2.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.